KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Capital Expenditures Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.94%
Dec 31, 2025 5.51%
Sep 30, 2025 15.90%
Jun 30, 2025 22.47%
Mar 31, 2025 6.93%
Dec 31, 2024 8.53%
Sep 30, 2024 11.26%
Jun 30, 2024 6.53%
Mar 31, 2024 6.84%
Dec 31, 2023 2.62%
Sep 30, 2023 8.83%
Jun 30, 2023 5.52%
Mar 31, 2023 3.07%
Dec 31, 2022 6.38%
Sep 30, 2022 -1.17%
Jun 30, 2022 1.86%
Mar 31, 2022 -2.76%
Dec 31, 2021 -2.91%
Sep 30, 2021 -4.56%
Jun 30, 2021 -4.26%
Mar 31, 2021 -6.49%
Dec 31, 2020 -0.14%
Sep 30, 2020 -8.15%
Jun 30, 2020 -4.51%
Mar 31, 2020 6.46%
Dec 31, 2019 5.62%
Sep 30, 2019 12.17%
Jun 30, 2019 11.67%
Mar 31, 2019 11.57%
Dec 31, 2018 7.71%
Sep 30, 2018 12.56%
Jun 30, 2018 15.10%
Mar 31, 2018 15.76%
Dec 31, 2017 7.74%
Sep 30, 2017 13.85%
Jun 30, 2017 17.02%
Mar 31, 2017 18.79%
Dec 31, 2016 22.59%
Sep 30, 2016 32.34%
Jun 30, 2016 28.67%
Mar 31, 2016 26.40%
Dec 31, 2015 17.92%
Sep 30, 2015 21.33%
Jun 30, 2015 15.29%
Mar 31, 2015 1.06%
Dec 31, 2014 -0.52%
Sep 30, 2014 -8.74%